Eterna Therapeutics Investigates ERNA-101 in Cancer Models
Eterna Therapeutics, a preclinical-stage company, announced a research collaboration with MD Anderson Cancer Center to evaluate its lead induced mesenchymal stem cell therapy, ERNA-101, for treating ovarian and breast cancers. ERNA-101, a proprietary allogenic cell therapy, aims to stimulate antitumor immunity. The research will assess ERNA-101’s effects both in vitro and in vivo, with potential future studies exploring […]
The Amazing Connection Between Ozone Therapy and Stem Cells: A Natural Path to Healing
Think of your body as a bustling city, where stem cells are like the construction workers ready to repair and rebuild damaged areas. Now, imagine ozone as their cup of morning coffee – giving them the boost they need to work faster and more efficiently. Pretty neat, right? The Science Behind the Magic When it […]
FDA Approves StemCyte’s REGENECYTE™ Cord Blood Therapy
StemCyte Inc. announced FDA approval of its REGENECYTE™ cord blood stem cell therapy for treating blood and immune system disorders, making them the first U.S.-based biotech company to receive such a biologics license for this therapy in 2024. REGENECYTE™ is an allogeneic therapy derived from umbilical cord blood. The company is also exploring other applications […]
Endogenous Stem Cell Mobilization: A Natural Approach to Supporting Kidney Health
Your kidneys work tirelessly as your body’s cleanup crew, filtering waste and maintaining balance 24/7. When these vital organs need support, your body’s own stem cells may hold the key to giving them a helping hand. Understanding ESCM and Kidney Function Endogenous Stem Cell Mobilization (ESCM) refers to the natural process of releasing stem cells […]
Can Stem Cell Therapy Cure Hearing Loss?
In the video below, “Using Stem Cells to Cure Hearing Loss?” Dr. Cliff Olson discusses the potential and challenges of using stem cell transplants to treat hearing loss. The video begins by highlighting the magnitude of hearing loss as a global health problem, citing the World Health Organization’s statistics that nearly 1.5 billion people currently […]
Revolutionary Stem Cell Therapy Shows Promising Improvements for Children with Autism
In a groundbreaking development in stem cell research, families of children with autism are seeing life-changing transformations. Highlighted in a recent Fox 17 News report, parents share heartfelt stories of their children’s behavioral and developmental milestones achieved through stem cell therapy. From improved social interactions to newfound verbal abilities, the therapy offered by the Kellum […]
BioRestorative Therapies Expands Stem Cell Research with New York State License
In a significant advancement for regenerative medicine, BioRestorative Therapies, Inc. has secured a provisional license from the New York State Department of Health (NYSDOH) to process allogeneic (non-autologous) donor tissue material, including stem cells, for medical research. This expansion builds upon their previous authorization, which was limited to autologous (self-donated) mesenchymal stem cells. This new […]
Unlocking the Power of Stem Cells: Dr. Adeel Khan’s Comprehensive Guide
In the realm of regenerative medicine, stem cells represent a groundbreaking frontier that could redefine how we treat chronic pain, autoimmune conditions, and even the process of aging. In Dr. Adeel Khan’s insightful talk, he delves deep into the science of stem cells and peptides, exploring the transformative potential of these cells and the challenges […]
Pioneering Stem Cell Therapy Shows Promise in Alzheimer’s Treatment: Regeneration Biomedical Releases First Cohort Results
In a breakthrough for Alzheimer’s disease research, Regeneration Biomedical, Inc. recently presented promising findings from a Phase I clinical trial that delivers stem cell therapy directly into the brains of patients. Utilizing Wnt-activated, autologous, expanded, adipose-derived stem cells (RB-ADSCs), the therapy is designed to potentially slow or reverse the progression of Alzheimer’s. These specialized stem […]
BioCardia Completes Phase III Clinical Trial of Autologous Stem Cell Therapy for Ischemic Heart Failure
BioCardia, Inc., a leader in cellular therapies for cardiovascular diseases, has announced the completion of its pivotal Phase III trial for CardiAMP®, an autologous cell therapy designed to treat ischemic heart failure with reduced ejection fraction (HFrEF). This milestone marks the last patient follow-up in the double-blind, placebo-controlled trial, which aims to assess the safety […]